Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
Scientific Reports|July 23, 2021
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imagingHamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, et al.Head & Neck|September 2, 2022
Multi-institutional review of sinonasal and skull base chondrosarcoma: 20-year experienceJacob G Eide, Rijul S Kshirsagar, Jacob C Harris, et al.Neuro-Oncology Advances|February 13, 2025
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendrogliomaCarson A Wills, Suyash Mohan, Ali Nabavizadeh, et al.Neuro-Oncology Advances|December 11, 2024
Enhancing clinical decision-making: An externally validated machine learning model for predicting isocitrate dehydrogenase mutation in gliomas using radiomics from presurgical magnetic resonance imagingJan Lost, Nader Ashraf, Leon Jekel, et al.Journal of Neuro-Oncology|January 19, 2022
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastomaAmir Nazem, Samantha C Guiry, Mehrdad Pourfathi, et al.Journal of Imaging Informatics in Medicine|March 22, 2024
Active Learning in Brain Tumor Segmentation with Uncertainty Sampling and Annotation Redundancy RestrictionDaniel D Kim, Rajat S Chandra, Li Yang, et al.Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.Neoplasia (New York, N.Y.)|December 25, 2022
Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markersDebanjan Haldar, Anahita Fathi Kazerooni, Sherjeel Arif, et al.Neuro-Oncology Advances|April 30, 2026
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 gliomaElizabeth C Cordell, Maikel Mansour, Austin R Pantel, et al.Nature Communications|June 9, 2021
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40Fan Yang, Zhenqiang He, Hao Duan, et al.Pageof 15